dacarbazine
Dacarbazine was approved for medical use in the United States in 1975. It is also known as imidazole carboxamide, is a chemotherapy medication used in the treatment of melanoma and Hodgkin's lymphoma.. Reference standards of Dacarbazine API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
stdClass Object
(
[pname] => Dacarbazine (Y0000733)
[catalogue_number] => PA EPY0000733
[category_ids] => ,150,
[chemical_name] =>
[weight] => NA
[form] => NA
[cas] => NA
[pslug] => dacarbazine-y0000733-paepy0000733
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
stdClass Object
(
[pname] => Dacarbazine impurity A (Y0000734)
[catalogue_number] => PA EPY0000734
[category_ids] => ,150,
[chemical_name] =>
[weight] => NA
[form] => NA
[cas] => NA
[pslug] => dacarbazine-impurity-a-y0000734-paepy0000734
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Dacarbazine impurity A (Y0000734)
stdClass Object
(
[pname] => Dacarbazine impurity B (Y0000735)
[catalogue_number] => PA EPY0000735
[category_ids] => ,150,
[chemical_name] =>
[weight] => NA
[form] => NA
[cas] => NA
[pslug] => dacarbazine-impurity-b-y0000735-paepy0000735
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Dacarbazine impurity B (Y0000735)
